These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30921705)

  • 1. Chemoresistance mechanisms of breast cancer and their countermeasures.
    Ji X; Lu Y; Tian H; Meng X; Wei M; Cho WC
    Biomed Pharmacother; 2019 Jun; 114():108800. PubMed ID: 30921705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding Novel Mechanisms and Emerging Therapeutic Strategies in Breast Cancer Resistance.
    Shafi S; Khan S; Hoda F; Fayaz F; Singh A; Khan MA; Ali R; Pottoo FH; Tariq S; Najmi AK
    Curr Drug Metab; 2020; 21(3):199-210. PubMed ID: 32124694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor α roles in breast cancer chemoresistance.
    Xu CY; Jiang ZN; Zhou Y; Li JJ; Huang LM
    Asian Pac J Cancer Prev; 2013; 14(7):4049-52. PubMed ID: 23991950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of MicroRNAs in the Chemoresistance of Breast Cancer.
    Wang J; Yang M; Li Y; Han B
    Drug Dev Res; 2015 Nov; 76(7):368-74. PubMed ID: 26310899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic approaches in breast cancer.
    Davies E; Hiscox S
    Maturitas; 2011 Feb; 68(2):121-8. PubMed ID: 21144683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
    Yakisich JS; Venkatadri R; Azad N; Iyer AKV
    J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics for identifying mechanisms and biomarkers of drug resistance in cancer.
    Li XH; Li C; Xiao ZQ
    J Proteomics; 2011 Nov; 74(12):2642-9. PubMed ID: 21964283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer.
    El-Tanani M; Nsairat H; Aljabali AA; Matalka II; Alkilany AM; Tambuwala MM
    Expert Opin Drug Deliv; 2024 Feb; 21(2):309-324. PubMed ID: 38284386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of breast cancer chemoresistance by immune checkpoints.
    Dastmalchi N; Safaralizadeh R; Baghbanzadeh A; Hajiasgharzadeh K; Roshani Asl E; Amini M; Baradaran B
    Life Sci; 2020 Dec; 263():118604. PubMed ID: 33096117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Combined Gene Expression Profile in Implementing a Drug Sensitivity Predictive Model for Breast Cancer.
    Zhang X; Cha IH; Kim KY
    Cancer Res Treat; 2017 Jan; 49(1):116-128. PubMed ID: 27188202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted multidrug delivery system to overcome chemoresistance in breast cancer.
    Tang Y; Soroush F; Tong Z; Kiani MF; Wang B
    Int J Nanomedicine; 2017; 12():671-681. PubMed ID: 28176940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance in chemotherapy for breast cancer.
    Saeki T; Tsuruo T; Sato W; Nishikawsa K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies.
    Li W; Zhang H; Assaraf YG; Zhao K; Xu X; Xie J; Yang DH; Chen ZS
    Drug Resist Updat; 2016 Jul; 27():14-29. PubMed ID: 27449595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.
    Si W; Shen J; Du C; Chen D; Gu X; Li C; Yao M; Pan J; Cheng J; Jiang D; Xu L; Bao C; Fu P; Fan W
    Cell Death Differ; 2018 Feb; 25(2):406-420. PubMed ID: 29125598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
    Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
    Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.